Directors Beware: New Swedish judgment regarding personal liability for patent infringement

In Insights

8 December, 2017
Directors Beware: New Swedish judgment regarding personal liability for patent infringement for the directors of a company

The Swedish Patent and Market Court (PMD) announced an interesting judgment concerning the Board of Directors’ personal liability for patent infringement in October this year.
The company Power Tools sued the company Royex, its chairman and president for patent infringement of cartridges for cracking stones. PMD found that the product “Royex Generation II” constitutes patent infringement. The PMD specifically examined what is required for a company representative, and not just the company as such, to be considered to have infringed on a patent. Practice shows, according to the PMD, that an individual-level test is required of what can be added to each other and a relatively comprehensive investigation as to what actions the individual has done.

According to the PMD, there is no support for deputies and ownership in a limited liability company by itself which is sufficient for anyone to be considered to have infringed on intellectual property rights when the infringement occurs within the framework of the company’s operations. The person must himself have taken the actions that constitute the intrusion.

The PMD found that the Chairman of the Board had taken decisions that later led Royex to offer and sell the Royex Generation II product to its customers. This means, according to the PMD, that the Chairman of the Board, with his advice and deeds promoted the company’s actions in a way that contributed to patent infringement. PMD continued with a comparison with the so-called Pirate Bay, ruling that a representative of a company may be responsible for paying compensation and damages the in case of patent infringement if the representative has contributed to the intrusion as a result of intent or negligence. According to the PMD, the investigation in this case did not support the Chairman of the Board knowing or being suspected of involvement in patent infringement. There was also no reason to believe that he would have acted in the same way if he had known or suspected it. Therefore, PMD did not consider that the Chairman of the Board acted intentionally.

The PMD also tried if the Chairman had acted negligently. The court referred to the fact that, in practice and law enforcement, a diligence standard had been imposed on intellectual property infringement. The person who deals with products that may be protected by copyright has, for example, a duty of inquiry regarding the goods he purchases. This duty is adapted to product range, supplier and the risk of copyright infringement. The same applies to those who deal with goods that may be counterfeit. PMD therefore found that the manufacturer and distributor of products in a patented area may be expected to stay informed of the patent portfolio in the area. This is especially true in markets with few players and where a company’s main competitor has a patent.

What is applicable for a company should, according to the PMD, also apply to the professional leader of the company. The Chairman of the Board had taken decisions that led Royex to offer and sell the Royex Generation II product. Therefore, he had reason to stay informed. The Chairman of the Board had acted negligently, and in solidarity with Royex, he had to pay reasonable compensation as well as compensation for the further damage that Power Tools has suffered due to the patent infringement. PMD also announced a prohibition of SEK 1 million against the board member.

The judgment implies an interesting development of practices regarding directors’ personal liability in the event of infringement of intellectual property rights. The verdict should provide all boards, at least boards of small and medium-sized companies, with a reason to review liability for patent infringement in connection with product launches and the like and to keep these issues up to date.

Co-author: Peter Kenamets, Attorney at Law and Partner

You may also be interested in:

AI and Intellectual Property

In this webinar from December 2024, Henrik Aurell, European Patent Attorney, and Hanna Hansson, IP Lawyer, deliver a presentation

Read more...

New rules for medical devices and in vitro diagnostic medical devices

In recent years, several new and amended requirements have been introduced for medical devices and in vitro diagnostic devices

Read more...

Mobile Sliding Menu